Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | KCNN4 | O15554 | 10/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.41 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11842568 | 0.83 | CYP1A2 (0.70) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL7987418 | 0.80 | CYP1A2 (0.58) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL2547243 | 0.80 | CYP1A2 (0.65) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL9211554 | 0.79 | MAPT (0.54) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL7593594 | 0.79 | MAPT (0.54) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL6961047 | 0.78 | CYP1A2 (0.56) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL3936932 | 0.78 | MAPT (0.58) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL3086830 | 0.78 | CYP1A2 (0.56) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL8818467 | 0.78 | CYP1A2 (0.56) | MAPTKMT2ACYP1A2KCNN4TSHR | |
| SCHEMBL9518780 | 0.77 | CYP1A2 (0.56) | MAPTKMT2ACYP1A2KCNN4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119775535-A | Pure cation system photosensitive resin composition and preparation method thereof | 上海信斯帝克新材料有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-4801706-A | ANTIARRHYTHMIA HYPOTENSIVE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-01-31 | — | — | US | claimed |
| EP-0046859-B1 | PROCESS FOR THE PREPARATION OF 1-BROMO-3,5-DICHLOROBENZENE | BASF Aktiengesellschaft (DE) | 1983-07-06 | — | — | EP | claimed |
| EP-0046859-A1 | Process for the preparation of 1-bromo-3,5-dichlorobenzene | BASF Aktiengesellschaft (DE) | 1982-03-10 | — | — | EP | claimed |
| CN-119775535-A | Pure cation system photosensitive resin composition and preparation method thereof | 上海信斯帝克新材料有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-105859692-B | Thioether compound containing pyrimidine, thiadiazole ring and amide structure and application thereof | 浙江工业大学 | 2018-02-27 | — | — | CN | disclosed |
| CN-105859692-A | Thioether compound containing pyrimidine, thiadiazole ring and amide structure and application thereof | 浙江工业大学 | 2016-08-17 | — | — | CN | disclosed |
| US-20090298781-A1 | COMPOUNDS FOR THE INHIBITION OF APOPTOSIS | CONSEJO SUPERIOR DE (ES) | 2009-12-03 | — | — | US | disclosed |
| US-7417027-B2 | Linear and cyclic melanocortin receptor-specific peptides | PALATIN TECHNOLOGIES, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| EP-1319642-B1 | Method of Preparing a Halogenated Compound | OTSUKA KAGAKU KK (JP) | 2008-03-26 | — | — | EP | disclosed |
| EP-1132391-B1 | PROCESS FOR THE PREPARATION OF 3-SULFONYLOXY-3-CEPHEM COMPOUNDS | OTSUKA KAGAKU KK (JP) | 2006-11-15 | — | — | EP | disclosed |
| EP-1447406-B1 | 3-Cephem derivative crystal | OTSUKA KAGAKU KK (JP) | 2006-08-09 | — | — | EP | disclosed |
| EP-0445821-A1 | Process for preparing a 3-formylcephem derivative | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1991-09-11 | — | — | EP | disclosed |
| EP-0444708-A2 | Process for preparation of beta-lactam derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1991-09-04 | — | — | EP | disclosed |
| US-4801706-A | ANTIARRHYTHMIA HYPOTENSIVE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-01-31 | — | — | US | disclosed |
| US-4801706-A | ANTIARRHYTHMIA HYPOTENSIVE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-01-31 | — | — | US | disclosed |
| EP-0046859-B1 | PROCESS FOR THE PREPARATION OF 1-BROMO-3,5-DICHLOROBENZENE | BASF Aktiengesellschaft (DE) | 1983-07-06 | — | — | EP | disclosed |
| EP-0046859-A1 | Process for the preparation of 1-bromo-3,5-dichlorobenzene | BASF Aktiengesellschaft (DE) | 1982-03-10 | — | — | EP | disclosed |
| EP-0046859-A1 | Process for the preparation of 1-bromo-3,5-dichlorobenzene | BASF Aktiengesellschaft (DE) | 1982-03-10 | — | — | EP | disclosed |
| US-4075007-A | N-chloro-chloroacetamides as herbicides | NATIONAL PATENT DEVELOPMENT CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298781-A1 | COMPOUNDS FOR THE INHIBITION OF APOPTOSIS | BAX, BCL2, CASP3 | MAPT 1796/4885KMT2A 4770/4885CYP1A2 2273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.